Home
About
FAQ
History (3)
Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1.
Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study.
Uterine leiomyosarcoma metastatic to soft tissue of the flank following a ten-year disease-free interval.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1.
Oechsel KF, Cartwright MS. Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1. Muscle Nerve. 2021 Oct; 64(4):487-490.
View in:
PubMed
subject areas
Azo Compounds
Biological Products
Combined Modality Therapy
Drug Therapy, Combination
Female
Humans
Infant
Male
Pyrimidines
Recombinant Fusion Proteins
Retrospective Studies
Spinal Muscular Atrophies of Childhood
authors with profiles
Michael S. Cartwright MD